Global Gene Therapy on Neurological Diseases Market Research Report 2023

Gene Therapy on Neurological Diseases Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Therapy on Neurological Diseases market research.

The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gene Therapy on Neurological Diseases market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Gene Therapy on Neurological Diseases Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Viral Gene Therapy

1.2.3 Non-viral Gene Therapy

1.3 Market by Application

1.3.1 Global Gene Therapy on Neurological Diseases Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Gene Therapy on Neurological Diseases Market Perspective (2018-2029)

2.2 Gene Therapy on Neurological Diseases Growth Trends by Region

2.2.1 Global Gene Therapy on Neurological Diseases Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Gene Therapy on Neurological Diseases Historic Market Size by Region (2018-2023)

2.2.3 Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029)

2.3 Gene Therapy on Neurological Diseases Market Dynamics

2.3.1 Gene Therapy on Neurological Diseases Industry Trends

2.3.2 Gene Therapy on Neurological Diseases Market Drivers

2.3.3 Gene Therapy on Neurological Diseases Market Challenges

2.3.4 Gene Therapy on Neurological Diseases Market Restraints

3.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue

3.1.1 Global Top Gene Therapy on Neurological Diseases Players by Revenue (2018-2023)

3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2018-2023)

3.2 Global Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Therapy on Neurological Diseases Revenue

3.4 Global Gene Therapy on Neurological Diseases Market Concentration Ratio

3.4.1 Global Gene Therapy on Neurological Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy on Neurological Diseases Revenue in 2022

3.5 Gene Therapy on Neurological Diseases Key Players Head office and Area Served

3.6 Key Players Gene Therapy on Neurological Diseases Product Solution and Service

3.7 Date of Enter into Gene Therapy on Neurological Diseases Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2018-2023)

4.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029)

5.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2018-2023)

5.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029)

6.1 North America Gene Therapy on Neurological Diseases Market Size (2018-2029)

6.2 North America Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)

6.4 North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Gene Therapy on Neurological Diseases Market Size (2018-2029)

7.2 Europe Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)

7.4 Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Gene Therapy on Neurological Diseases Market Size (2018-2029)

8.2 Asia-Pacific Gene Therapy on Neurological Diseases Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2023)

8.4 Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Gene Therapy on Neurological Diseases Market Size (2018-2029)

9.2 Latin America Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)

9.4 Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Gene Therapy on Neurological Diseases Market Size (2018-2029)

10.2 Middle East & Africa Gene Therapy on Neurological Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2023)

10.4 Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Biogen

11.1.1 Biogen Company Detail

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Therapy on Neurological Diseases Introduction

11.1.4 Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)

11.1.5 Biogen Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Therapy on Neurological Diseases Introduction

11.2.4 Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)

11.2.5 Novartis Recent Development

11.3 Sarepta Therapeutics

11.3.1 Sarepta Therapeutics Company Detail

11.3.2 Sarepta Therapeutics Business Overview

11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Introduction

11.3.4 Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2023)

11.3.5 Sarepta Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Viral Gene Therapy

    Table 3. Key Players of Non-viral Gene Therapy

    Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Gene Therapy on Neurological Diseases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Gene Therapy on Neurological Diseases Market Share by Region (2018-2023)

    Table 8. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Gene Therapy on Neurological Diseases Market Share by Region (2024-2029)

    Table 10. Gene Therapy on Neurological Diseases Market Trends

    Table 11. Gene Therapy on Neurological Diseases Market Drivers

    Table 12. Gene Therapy on Neurological Diseases Market Challenges

    Table 13. Gene Therapy on Neurological Diseases Market Restraints

    Table 14. Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Gene Therapy on Neurological Diseases Market Share by Players (2018-2023)

    Table 16. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)

    Table 17. Ranking of Global Top Gene Therapy on Neurological Diseases Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Gene Therapy on Neurological Diseases Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Gene Therapy on Neurological Diseases Product Solution and Service

    Table 21. Date of Enter into Gene Therapy on Neurological Diseases Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2023)

    Table 25. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2024-2029)

    Table 27. Global Gene Therapy on Neurological Diseases Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2018-2023)

    Table 29. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2024-2029)

    Table 31. North America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Gene Therapy on Neurological Diseases Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Biogen Company Detail

    Table 47. Biogen Business Overview

    Table 48. Biogen Gene Therapy on Neurological Diseases Product

    Table 49. Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)

    Table 50. Biogen Recent Development

    Table 51. Novartis Company Detail

    Table 52. Novartis Business Overview

    Table 53. Novartis Gene Therapy on Neurological Diseases Product

    Table 54. Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)

    Table 55. Novartis Recent Development

    Table 56. Sarepta Therapeutics Company Detail

    Table 57. Sarepta Therapeutics Business Overview

    Table 58. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product

    Table 59. Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2023) & (US$ Million)

    Table 60. Sarepta Therapeutics Recent Development

    Table 61. Research Programs/Design for This Report

    Table 62. Key Data Information from Secondary Sources

    Table 63. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Gene Therapy on Neurological Diseases Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Gene Therapy on Neurological Diseases Market Share by Type: 2022 VS 2029

    Figure 3. Viral Gene Therapy Features

    Figure 4. Non-viral Gene Therapy Features

    Figure 5. Global Gene Therapy on Neurological Diseases Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Gene Therapy on Neurological Diseases Market Share by Application: 2022 VS 2029

    Figure 7. Hospital Case Studies

    Figure 8. Clinic Case Studies

    Figure 9. Other Case Studies

    Figure 10. Gene Therapy on Neurological Diseases Report Years Considered

    Figure 11. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Gene Therapy on Neurological Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Gene Therapy on Neurological Diseases Market Share by Region: 2022 VS 2029

    Figure 14. Global Gene Therapy on Neurological Diseases Market Share by Players in 2022

    Figure 15. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy on Neurological Diseases Revenue in 2022

    Figure 17. North America Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)

    Figure 19. United States Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)

    Figure 23. Germany Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2018-2029)

    Figure 31. China Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)

    Figure 39. Mexico Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)

    Figure 43. Turkey Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Biogen Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)

    Figure 46. Novartis Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)

    Figure 47. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2023)

    Figure 48. Bottom-up and Top-down Approaches for This Report

    Figure 49. Data Triangulation

    Figure 50. Key Executives Interviewed